Looker Benjamin 4

What Happened Benjamin Looker, Chief Legal Officer of Esperion Therapeutics (ESPR), sold 11,824 shares on 2026-06-17 at $3.15 per share, generating proceeds of $37,305. The sale is reported as an open-market or private sale and is a disposition (code S). This was a tax-related sale tied to vested restricted stock units rather than a buy.

Key Details

• Transaction date: 2026-06-17; Filing date: 2026-06-18 (timely filing).
• Price and amount: 11,824 shares @ $3.15 = $37,305 total.
• Method: Open market or private sale (listed as sale, code S).
• Footnote: F1 — shares were sold to satisfy tax obligations on vested RSUs (tax withholding).
• Shares owned after transaction: Not specified in this filing.
• No indication of a 10b5-1 plan or late filing in the report.

Context Tax-withholding sales following RSU vesting are common and are administrative in nature; they do not necessarily reflect the insider's view of the company's longer-term prospects. For retail investors, purchases or non-tax-driven sales can be more informative about sentiment.